Abstract

BackgroundThe occurrence of multimorbidity (i.e., the coexistence of multiple chronic diseases) increases with age in older adults and is a growing concern worldwide. Multimorbidity has been reported to be a driving factor in the increase of medical expenditures in OECD countries. However, to the best of our knowledge, there is no published research that has examined the associations between multimorbidity and either long-term care (LTC) expenditure or the sum of medical and LTC expenditures worldwide. We, therefore, aimed to examine the associations of multimorbidity with the sum of medical and LTC expenditures for older adults in Japan.MethodsMedical insurance claims data for adults ≥75 years were merged with LTC insurance claims data from Kashiwa city, a suburb in the Tokyo metropolitan area, for the period between April 2012 and September 2013 to obtain an estimate of medical and LTC expenditures. We also calculated the 2011 updated and reweighted version of the Charlson Comorbidity Index (CCI) scores. Then, we performed multiple generalized linear regressions to examine the associations of CCI scores (0, 1, 2, 3, 4, or ≥ 5) with the sum of annual medical and LTC expenditures, adjusting for age, sex, and household income level.ResultsThe mean sum of annual medical and LTC expenditures was ¥1,086,000 (US$12,340; n = 30,042). Medical and LTC expenditures accounted for 66 and 34% of the sum, respectively. Every increase in one unit of the CCI scores was associated with a ¥257,000 (US$2920); 95% Confidence Interval: ¥242,000, 271,000 (US$2750, 3080) increase in the sum of the expenditures (p < 0.001; n = 29,915).ConclusionsUsing a merged medical and LTC claims dataset, we found that greater CCI scores were associated with a higher sum of annual medical and LTC expenditures for older adults. To the best of our knowledge, this is the first study to examine the associations of multimorbidity with LTC expenditures or the sum of medical and LTC expenditures worldwide. Our study indicated that the economic burden on society caused by multimorbidity could be better evaluated by the sum of medical and LTC expenditures, rather than medical expenditures alone.

Highlights

  • The occurrence of multimorbidity increases with age in older adults and is a growing concern worldwide

  • In some instances, the diseases or medical conditions we included did vary from the original definitions

  • Our study indicated that greater multimorbidity was associated with higher medical expenditures, which was consistent with the results from other Organisation for Economic Co-operation and Development (OECD) countries [7, 8, 23]

Read more

Summary

Introduction

The occurrence of multimorbidity (i.e., the coexistence of multiple chronic diseases) increases with age in older adults and is a growing concern worldwide. To the best of our knowledge, there is no published research that has examined the associations between multimorbidity and either long-term care (LTC) expenditure or the sum of medical and LTC expenditures worldwide. In Japan, the annual medical expenditures in 2016 were approximately ¥42.1 trillion (approximately US$372 billion per the 2016 exchange rate) [2, 3], and the annual long-term care (LTC) expenditures in 2016 were approximately ¥10.0 trillion (approximately US$88 billion) [4] These expenditures are projected to further increase with a rapidly aging society, as is the case with many OECD countries [1, 5]. In Japan, to the best of our knowledge, no population-based study has been published that examined the associations of overall multimorbidity with medical expenditures. There have been a few studies that have focused on the associations between specific medical conditions (e.g., hypertension) and medical expenditures [10, 11] but not the associations between overall multimorbidity and medical expenditures

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call